This is similar to other NSCLC cell lines that do not contain ALK or ROS1 fusions (H322 and HCC4006), suggesting that the anti-proliferative effects in this range are likely due to off-target activities. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.